Similar articles for PMID: 23266123

Year	Number of Results
1996	1
1998	1
1999	2
2000	2
2001	3
2002	2
2003	4
2004	4
2005	3
2006	3
2007	2
2008	4
2009	2
2010	2
2011	6
2012	6
2013	7
2014	8
2015	10
2016	13
2017	9
2018	6
2019	6
2020	3
2021	4
2022	1
2024	0

1

Triazole-based inhibitors of geranylgeranyltransferase II.

Zhou X, Hartman SV, Born EJ, Smits JP, Holstein SA, Wiemer DF. Zhou X, et al. Bioorg Med Chem Lett. 2013 Feb 1;23(3):764-6. doi: 10.1016/j.bmcl.2012.11.089. Epub 2012 Dec 1. Bioorg Med Chem Lett. 2013. PMID: 23266123 Free PMC article.

2

Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

Fairweather AER, Goetz DB, Schroeder CM, Bhuiyan NH, Varney ML, Wiemer DF, Holstein SA. Fairweather AER, et al. Bioorg Med Chem. 2021 Aug 15;44:116307. doi: 10.1016/j.bmc.2021.116307. Epub 2021 Jul 11. Bioorg Med Chem. 2021. PMID: 34298413 Free PMC article.

3

α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

Matthiesen RA, Varney ML, Xu PC, Rier AS, Wiemer DF, Holstein SA. Matthiesen RA, et al. Bioorg Med Chem. 2018 Jan 15;26(2):376-385. doi: 10.1016/j.bmc.2017.10.023. Epub 2017 Oct 19. Bioorg Med Chem. 2018. PMID: 29248353 Free PMC article.

4

Amides as bioisosteres of triazole-based geranylgeranyl diphosphate synthase inhibitors.

Goetz DB, Varney ML, Wiemer DF, Holstein SA. Goetz DB, et al. Bioorg Med Chem. 2020 Aug 15;28(16):115604. doi: 10.1016/j.bmc.2020.115604. Epub 2020 Jun 30. Bioorg Med Chem. 2020. PMID: 32690260 Free PMC article.

5

Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors.

Legigan T, Migianu-Griffoni E, Redouane MA, Descamps A, Deschamp J, Gager O, Monteil M, Barbault F, Lecouvey M. Legigan T, et al. Eur J Med Chem. 2021 Mar 15;214:113241. doi: 10.1016/j.ejmech.2021.113241. Epub 2021 Feb 2. Eur J Med Chem. 2021. PMID: 33571830

6

Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.

Zhou X, Ferree SD, Wills VS, Born EJ, Tong H, Wiemer DF, Holstein SA. Zhou X, et al. Bioorg Med Chem. 2014 May 1;22(9):2791-8. doi: 10.1016/j.bmc.2014.03.014. Epub 2014 Mar 24. Bioorg Med Chem. 2014. PMID: 24726306 Free PMC article.

7

Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.

Wills VS, Metzger JI, Allen C, Varney ML, Wiemer DF, Holstein SA. Wills VS, et al. Bioorg Med Chem. 2017 Apr 15;25(8):2437-2444. doi: 10.1016/j.bmc.2017.02.066. Epub 2017 Mar 4. Bioorg Med Chem. 2017. PMID: 28302510 Free PMC article.

8

Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.

Pautus S, Yee SW, Jayne M, Coogan MP, Simons C. Pautus S, et al. Bioorg Med Chem. 2006 Jun 1;14(11):3643-53. doi: 10.1016/j.bmc.2006.01.018. Epub 2006 Feb 3. Bioorg Med Chem. 2006. PMID: 16458519

9

A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.

Sajja Y, Vanguru S, Jilla L, Vulupala HR, Bantu R, Yogeswari P, Sriram D, Nagarapu L. Sajja Y, et al. Bioorg Med Chem Lett. 2016 Sep 1;26(17):4292-5. doi: 10.1016/j.bmcl.2016.07.039. Epub 2016 Jul 20. Bioorg Med Chem Lett. 2016. PMID: 27476139

10

Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors.

Minutolo F, Antonello M, Barontini S, Bertini S, Betti L, Danesi R, Gervasi G, Giannaccini G, Papi C, Placanica G, Rapposelli S, Macchia M. Minutolo F, et al. Farmaco. 2004 Nov;59(11):887-92. doi: 10.1016/j.farmac.2004.08.002. Farmaco. 2004. PMID: 15544793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year